Stock listing

HKEX:2181 Mabpharm Limited (邁博藥業) 股價

Follow Mabpharm Limited into a list and get an email when it puts out news.

Share price · HKEX:2181

$0.47 HKD 0.00 (0.0%)

Close on Nov 20, 2026

Past year -9.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$0.47 – $0.47 HKDNov 20, 2026
Market cap
$1.94B HKDAt the close on Nov 20, 2026 · price × 4.12B shares outstanding
52-week range
$0.31 – $0.81 HKDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$20,035 HKDMedian day 20,000 shares · 17 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026
Mabpharm Limited logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · HKEX:2181 · HKD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.470.000.0%$0.47$0.47$0.470
$0.47-0.025-5.1%$0.47$0.47$0.470
$0.495+0.005+1.0%$0.435$0.495$0.43534,000
$0.490.000.0%$0.425$0.51$0.42522,000
$0.490.000.0%$0.49$0.49$0.490
$0.49+0.05+11.4%$0.425$0.51$0.42522,000
$0.440.000.0%$0.44$0.44$0.442,000
$0.44-0.04-8.3%$0.43$0.44$0.4326,000
$0.480.000.0%$0.48$0.48$0.480
$0.480.000.0%$0.48$0.48$0.480
$0.48+0.015+3.2%$0.425$0.485$0.42202,000
$0.465+0.04+9.4%$0.495$0.52$0.465260,000
$0.425-0.005-1.2%$0.435$0.435$0.425240,000
$0.43-0.005-1.1%$0.425$0.435$0.42522,000
$0.4350.000.0%$0.435$0.435$0.4350
$0.4350.000.0%$0.43$0.435$0.42572,000
$0.4350.000.0%$0.435$0.435$0.4350
$0.435-0.005-1.1%$0.425$0.435$0.425102,000
$0.44-0.02-4.3%$0.43$0.44$0.4342,000
$0.46+0.02+4.5%$0.495$0.50$0.4652,000
$0.44-0.06-12.0%$0.55$0.55$0.4436,000
$0.500.000.0%$0.50$0.50$0.5020,000
$0.500.000.0%$0.50$0.515$0.500
$0.500.000.0%$0.50$0.50$0.500
$0.500.000.0%$0.50$0.515$0.5080,000
$0.500.000.0%$0.50$0.515$0.5080,000
$0.50-0.005-1.0%$0.50$0.515$0.5080,000
$0.5050.000.0%$0.505$0.505$0.5050
$0.505+0.005+1.0%$0.50$0.515$0.5080,000
$0.500.000.0%$0.50$0.50$0.500
$0.500.000.0%$0.50$0.50$0.500
$0.50-0.005-1.0%$0.43$0.50$0.436,000
$0.505+0.015+3.1%$0.485$0.52$0.48520,000
$0.49+0.04+8.9%$0.495$0.495$0.492,000
$0.45-0.025-5.3%$0.535$0.535$0.4556,000
$0.475-0.02-4.0%$0.475$0.475$0.4750
$0.495-0.015-2.9%$0.495$0.495$0.4950
$0.51+0.115+29.1%$0.405$0.51$0.40516,000
$0.395+0.02+5.3%$0.35$0.40$0.3546,000
$0.375-0.045-10.7%$0.375$0.375$0.3752,000
$0.42+0.02+5.0%$0.42$0.50$0.4154,000
$0.40+0.01+2.6%$0.385$0.40$0.385210,000
$0.39-0.03-7.1%$0.41$0.41$0.39112,000
$0.420.000.0%$0.42$0.42$0.42120,000
$0.420.000.0%$0.44$0.44$0.4214,000
$0.42-0.015-3.4%$0.44$0.44$0.4214,000
$0.4350.000.0%$0.435$0.435$0.43520,000
$0.435-0.015-3.3%$0.42$0.435$0.4248,000
$0.45-0.025-5.3%$0.455$0.455$0.4522,000
$0.475+0.03+6.7%$0.415$0.495$0.4154,000
$0.4450.000.0%$0.445$0.445$0.4450
$0.4450.000.0%$0.445$0.445$0.44510,000
$0.4450.000.0%$0.445$0.445$0.44530,000
$0.4450.000.0%$0.445$0.445$0.4450
$0.4450.000.0%$0.445$0.445$0.44556,000
$0.4450.000.0%$0.445$0.445$0.4450
$0.445+0.01+2.3%$0.445$0.445$0.44550,000
$0.4350.000.0%$0.435$0.435$0.43510,000
$0.435+0.005+1.2%$0.43$0.435$0.40210,000
$0.430.000.0%$0.43$0.43$0.4320,000
$0.430.000.0%$0.41$0.50$0.4134,000
$0.43-0.005-1.1%$0.435$0.435$0.4320,000
$0.4350.000.0%$0.43$0.435$0.43122,000
$0.435+0.015+3.6%$0.43$0.435$0.43122,000
Ticker
HKEX:2181
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
HKEX
Currency
HKD

What changed lately

Latest news

All Mabpharm Limited news

Mabpharm Limited on 6ix

Sector
Health care
Industry
Biotechnology
News releases
5 in the last 12 months · 5 in all · newest Nov 3, 2026 · oldest 2026

Valuation

P/E 29.6× against a median of 10.3×: 3rd lowest of 4 Biotechnology companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$2.19B HKD
P/E
29.6×
EV/sales
3.0×
EV/EBITDA
28.9×
Price/book
8.5×
Gross margin
82.9%
Operating margin
0.7%
Net margin
8.8%
Debt to equity
1.6×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Mabpharm Limited · HKEX:2181US$247.3MUS$279.5M29.6×3.0×28.9×8.5×8.8%1.6×n/a
Eikon Therapeutics, Inc. · NASDAQ:EIKNUS$256.8MUS$44.67Mn/an/an/a0.7×n/a0.7×1.91
SAB Biotherapeutics, Inc. · NASDAQ:SABSUS$255.7MUS$156.5Mn/an/an/a1.2×n/a0.0×1.19
Evommune, Inc. · NYSE:EVMNUS$255.5MUS$86.86Mn/an/an/a1.0×n/a0.0×0.96
Editas Medicine, Inc. · NASDAQ:EDITUS$253.1MUS$119.7Mn/a2.4×n/a3.0×−144.9%0.7×2.22
Q32 Bio Inc. · NASDAQ:QTTBUS$249.6M−US$35.66M7.7×−0.7×−1.9×0.9×59.8%0.0×0.59
Turn Therapeutics Inc. · NASDAQ:TTRXUS$247.5MUS$244.2Mn/an/an/a43.5×n/a1.1×1.54
Lexeo Therapeutics, Inc. · NASDAQ:LXEOUS$245.1MUS$56.52Mn/an/an/a1.1×n/a0.0×1.62
Shandong Boan Biotechnology Company., Limited. Class H · HKEX:6955US$242.7MUS$92.94M226×0.8×4.6×0.6×0.9%0.0×n/a
Curocell, Inc. · KRX:372320US$239.8MUS$191.4Mn/an/an/a4.5×n/a0.2×n/a
Clinuvel Pharmaceuticals Limited · ASX:CUVUS$238.9MUS$73.38M10.3×1.1×2.6×1.3×36.0%0.0×n/a
Median of the othersUS$248.5MUS$89.90M10.3×1.0×2.6×1.2×18.5%0.0×1.54

Events

QuarterResultsShare move
Q2 2025Sep 22, 2025−5.1%
Quarter to Mar 31, 2025Apr 22, 2025−1.0%
Q4 2024Mar 26, 2025+1.8%

Open Events

Financials

Annual, in CNY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Revenue629.4M258.2M87.2M55.9M82.9M014.1M23.9M4.69M
Cost of revenue107.8M38.8M11.9M15.4M16.8M0
Gross profit521.5M219.4M75.2M40.5M66.1M014.1M23.9M4.69M
Research and development49.3M75.2M123.2M147.9M263.6M120.4M134.2M89.0M21.6M
Selling, general and administrative511.3M28.9M21.0M22.0M21.3M18.5M90.5M34.4M4.87M
Operating income4.68M-119.7M-202.0M-226.3M-297.5M-186.2M-194.8M-148.1M-44.4M
Depreciation and amortization59.8M61.3M60.7M51.5M43.9M24.4M22.2M11.7M10.1M
EBITDA64.5M-58.3M-141.3M-174.7M-253.6M-161.8M-172.6M-136.4M-34.3M
Interest expense10.5M10.6M9.58M7.19M2.40M3.94M7.70M4.48M3.33M
Income before tax4.05M-127.9M-209.4M-210.8M-291.7M-184.6M-202.5M-152.6M-47.7M
Income tax-51.6M-199.0K2.48M-2.83M
Net income55.7M-127.9M-209.4M-210.6M-291.7M-188.6M-210.2M-124.9M-31.1M
Earnings per share, basic0.01-0.03-0.05-0.05-0.07-0.05-0.05-0.03-0.01

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash and equivalents109.3M89.3M173.3M33.6M81.6M484.8M588.7M198.2M76.4M
Short-term investments015.0M0179.2M
Receivables163.9M96.1M19.4M9.53M793.0K1.22M6.88M2.27M484.0K
Inventory136.6M111.0M102.0M100.8M53.2M33.4M22.2M27.6M36.3M
Current assets434.5M365.8M342.2M201.1M247.8M569.1M955.1M260.8M154.9M
Property, plant and equipment569.0M614.2M686.5M704.0M561.0M512.6M332.4M122.8M113.1M
Total assets1.15B1.02B1.03B917.5M899.9M1.16B1.40B473.2M289.1M
Accounts payable30.2M11.7M10.0M16.6M12.9M4.52M4.51M1.80M1.09M
Current liabilities534.3M312.1M316.2M188.4M235.0M202.6M270.3M156.4M70.9M
Long-term debt66.3M165.5M101.5M84.7M0065.0M65.0M
Total debt326.9M293.1M260.1M126.3M46.4M40.3M214.3M105.0M75.0M
Total liabilities996.6M927.3M829.9M516.6M297.9M281.6M342.8M223.7M135.9M
Shareholders' equity157.4M88.9M205.1M400.9M602.0M881.5M1.05B249.6M99.8M
Shares outstanding4.12B4.12B4.12B4.12B4.12B4.12B4.12B4.12B4.12B

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operations80.8M-4.10M57.4M-56.9M-199.5M-147.2M-136.6M-61.9M-65.1M
Capital spending-104.0M-59.5M-19.0M-125.1M-148.7M-197.2M-113.6M-90.9M-13.1M
Free cash flow-23.2M-63.6M38.4M-182.0M-348.1M-344.5M-250.2M-152.8M-78.3M
Cash from investing-64.2M-98.2M-3.50M-105.0M-179.4M156.0M-413.1M-82.7M-13.6M
Cash from financing3.29M18.3M85.6M112.3M-17.8M-80.5M922.8M256.8M16.9M
Share buybacks01.03B410.5M0
Change in cash19.9M-84.0M139.8M-48.0M-403.3M-103.9M390.5M121.8M-33.2M

Open Financials

Filings

Open Filings

Cap table

Built by 6ix from Mabpharm Limited’s releases

Common shares
4,124,080,000
Fully diluted
4,124,080,000

Fully diluted

LineShares
Common shares4,124,080,000

Share count over time

CountShares
Nov 22, 20264,124,080,000

Open Cap table

Shareholders

HolderSharesOf the companyAs of
Asia Mabtech Limited2.23B54.0%May 31, 2019
Guo Jianjun2.23B54.0%Nov 28, 2023
Asia Pacific Immunotech Venture Limited2.23B54.0%May 31, 2019
Guo Family (PTC) Limited2.23B54.0%May 31, 2019
CDH Mabtech Limited742M18.0%May 31, 2019
China Diamond Holdings V Limited742M18.0%May 31, 2019
CDH Fund V, L.P.742M18.0%May 31, 2019
CDH V Holdings Company Limited742M18.0%May 31, 2019
China Diamond Holdings Company Limited742M18.0%May 31, 2019
Fortune-Healthy Investment Limited213M5.2%May 31, 2019
All 11 holders
HolderSharesOf the companyAs of
Link Best Capital Limited213M5.2%May 31, 2019

Open Shareholders

Log in to ask 6ix AI your own questions about Mabpharm Limited.